Phio Pharmaceuticals Corp Stock Price History
PHIO Stock | USD 0.67 0.03 4.14% |
Below is the normalized historical share price chart for Phio Pharmaceuticals Corp extending back to May 10, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phio Pharmaceuticals stands at 0.67, as last reported on the 24th of April, with the highest price reaching 0.83 and the lowest price hitting 0.66 during the day.
If you're considering investing in Phio Stock, it is important to understand the factors that can impact its price. Phio Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Phio Pharmaceuticals Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0603, which implies the firm had a 0.0603% return per unit of risk over the last 3 months. We have found thirty technical indicators for Phio Pharmaceuticals Corp, which you can use to evaluate the volatility of the company. Please evaluate Phio Pharmaceuticals' Coefficient Of Variation of 2342.21, semi deviation of 6.37, and Risk Adjusted Performance of 0.0358 to confirm if our risk estimates are consistent with your expectations.
At this time, Phio Pharmaceuticals' Stock Based Compensation To Revenue is very stable compared to the past year. . At this time, Phio Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 24th of April 2024, Price Sales Ratio is likely to grow to 275.10, while Price Earnings Ratio is likely to drop (0.15). Phio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2012 | 200 Day MA 1.3182 | 50 Day MA 0.7985 | Beta 1.418 |
Phio |
Sharpe Ratio = 0.0603
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | PHIO | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.71 actual daily | 68 68% of assets are less volatile |
Expected Return
0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Phio Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phio Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.4003 | Enterprise Value Ebitda 0.5099 | Price Sales 48.0082 | Shares Float 4.6 M | Wall Street Target Price 4 |
Phio Pharmaceuticals Stock Price History Chart
There are several ways to analyze Phio Stock price data. The simplest method is using a basic Phio candlestick price chart, which shows Phio Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 29, 2024 | 1.08 |
Lowest Price | January 29, 2024 | 0.58 |
Phio Pharmaceuticals April 24, 2024 Stock Price Synopsis
Various analyses of Phio Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Phio Stock. It can be used to describe the percentage change in the price of Phio Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Phio Stock.Phio Pharmaceuticals Price Action Indicator | (0.09) | |
Phio Pharmaceuticals Price Rate Of Daily Change | 0.96 | |
Phio Pharmaceuticals Price Daily Balance Of Power | (0.17) |
Phio Pharmaceuticals April 24, 2024 Stock Price Analysis
Phio Stock Price History Data
The price series of Phio Pharmaceuticals for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 0.53 with a coefficient of variation of 19.16. The price distribution for the period has arithmetic mean of 0.75. The median price for the last 90 days is 0.69. The company completed stock split (1:12) on 26th of January 2023. Phio Pharmaceuticals Corp had dividends distributed to its stock-holders on 2020-01-15.Open | High | Low | Close | Volume | ||
04/24/2024 | 0.70 | 0.83 | 0.66 | 0.67 | ||
04/23/2024 | 0.72 | 0.83 | 0.66 | 0.70 | 649,702 | |
04/22/2024 | 0.63 | 1.05 | 0.61 | 0.83 | 7,342,687 | |
04/19/2024 | 0.64 | 0.65 | 0.61 | 0.64 | 28,517 | |
04/18/2024 | 0.63 | 0.64 | 0.60 | 0.64 | 61,688 | |
04/17/2024 | 0.65 | 0.65 | 0.63 | 0.65 | 41,365 | |
04/16/2024 | 0.65 | 0.66 | 0.64 | 0.65 | 20,631 | |
04/15/2024 | 0.67 | 0.68 | 0.65 | 0.67 | 49,481 | |
04/12/2024 | 0.70 | 0.70 | 0.66 | 0.67 | 52,536 | |
04/11/2024 | 0.71 | 0.72 | 0.66 | 0.70 | 54,913 | |
04/10/2024 | 0.70 | 0.70 | 0.65 | 0.68 | 24,599 | |
04/09/2024 | 0.69 | 0.70 | 0.66 | 0.68 | 49,075 | |
04/08/2024 | 0.69 | 0.70 | 0.67 | 0.69 | 46,536 | |
04/05/2024 | 0.71 | 0.72 | 0.68 | 0.69 | 96,948 | |
04/04/2024 | 0.72 | 0.72 | 0.67 | 0.69 | 94,790 | |
04/03/2024 | 0.68 | 0.72 | 0.65 | 0.70 | 72,883 | |
04/02/2024 | 0.65 | 0.70 | 0.63 | 0.67 | 122,415 | |
04/01/2024 | 0.68 | 0.72 | 0.66 | 0.67 | 64,359 | |
03/28/2024 | 0.73 | 0.73 | 0.66 | 0.68 | 128,814 | |
03/27/2024 | 0.76 | 0.76 | 0.71 | 0.73 | 54,142 | |
03/26/2024 | 0.76 | 0.77 | 0.73 | 0.73 | 56,809 | |
03/25/2024 | 0.74 | 0.76 | 0.71 | 0.76 | 92,008 | |
03/22/2024 | 0.81 | 0.81 | 0.70 | 0.72 | 439,082 | |
03/21/2024 | 1.02 | 1.02 | 0.81 | 0.84 | 1,064,599 | |
03/20/2024 | 1.02 | 1.10 | 0.98 | 1.07 | 391,258 | |
03/19/2024 | 1.00 | 1.11 | 0.97 | 0.98 | 330,108 | |
03/18/2024 | 0.96 | 1.02 | 0.96 | 0.98 | 176,417 | |
03/15/2024 | 0.94 | 0.97 | 0.85 | 0.95 | 242,285 | |
03/14/2024 | 1.04 | 1.04 | 0.92 | 0.94 | 211,332 | |
03/13/2024 | 0.98 | 1.04 | 0.98 | 1.02 | 489,481 | |
03/12/2024 | 1.05 | 1.10 | 0.96 | 0.98 | 504,803 | |
03/11/2024 | 0.91 | 1.06 | 0.91 | 1.02 | 510,721 | |
03/08/2024 | 0.90 | 0.96 | 0.88 | 0.93 | 210,737 | |
03/07/2024 | 0.94 | 0.95 | 0.85 | 0.88 | 350,177 | |
03/06/2024 | 0.91 | 1.15 | 0.85 | 0.92 | 2,612,651 | |
03/05/2024 | 0.89 | 0.91 | 0.80 | 0.86 | 792,295 | |
03/04/2024 | 0.94 | 0.95 | 0.76 | 0.89 | 902,220 | |
03/01/2024 | 1.08 | 1.08 | 0.90 | 0.96 | 435,285 | |
02/29/2024 | 0.98 | 1.12 | 0.98 | 1.08 | 719,962 | |
02/28/2024 | 0.97 | 0.98 | 0.95 | 0.98 | 509,850 | |
02/27/2024 | 0.92 | 0.97 | 0.90 | 0.96 | 426,109 | |
02/26/2024 | 0.85 | 0.95 | 0.85 | 0.92 | 906,286 | |
02/23/2024 | 0.85 | 0.86 | 0.78 | 0.83 | 323,659 | |
02/22/2024 | 0.73 | 0.89 | 0.71 | 0.85 | 1,770,733 | |
02/21/2024 | 0.72 | 0.76 | 0.67 | 0.75 | 96,004 | |
02/20/2024 | 0.70 | 0.80 | 0.70 | 0.76 | 638,418 | |
02/16/2024 | 0.67 | 0.68 | 0.63 | 0.66 | 44,300 | |
02/15/2024 | 0.68 | 0.68 | 0.63 | 0.65 | 42,103 | |
02/14/2024 | 0.66 | 0.68 | 0.62 | 0.68 | 33,585 | |
02/13/2024 | 0.68 | 0.68 | 0.63 | 0.67 | 33,387 | |
02/12/2024 | 0.59 | 0.70 | 0.58 | 0.69 | 230,414 | |
02/09/2024 | 0.62 | 0.63 | 0.55 | 0.59 | 77,771 | |
02/08/2024 | 0.60 | 0.63 | 0.59 | 0.61 | 58,416 | |
02/07/2024 | 0.60 | 0.62 | 0.59 | 0.59 | 18,042 | |
02/06/2024 | 0.59 | 0.63 | 0.59 | 0.61 | 37,689 | |
02/05/2024 | 0.62 | 0.62 | 0.57 | 0.59 | 72,916 | |
02/02/2024 | 0.59 | 0.64 | 0.57 | 0.62 | 84,908 | |
02/01/2024 | 0.60 | 0.63 | 0.55 | 0.61 | 192,549 | |
01/31/2024 | 0.60 | 0.69 | 0.58 | 0.59 | 2,002,523 | |
01/30/2024 | 0.58 | 0.59 | 0.57 | 0.59 | 17,127 | |
01/29/2024 | 0.58 | 0.58 | 0.56 | 0.58 | 37,855 |
About Phio Pharmaceuticals Stock history
Phio Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phio Pharmaceuticals Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phio Pharmaceuticals stock prices may prove useful in developing a viable investing in Phio Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.1 M | 2.2 M | |
Net Loss | -15.3 M | -16 M |
Phio Pharmaceuticals Quarterly Net Working Capital |
|
Phio Pharmaceuticals Stock Technical Analysis
Phio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Phio Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phio Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0358 | |||
Jensen Alpha | 0.2139 | |||
Total Risk Alpha | (0.73) | |||
Sortino Ratio | 0.0304 | |||
Treynor Ratio | 0.2638 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Phio Stock analysis
When running Phio Pharmaceuticals' price analysis, check to measure Phio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phio Pharmaceuticals is operating at the current time. Most of Phio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Phio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.20) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.